Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Seasonal Flu Vaccine on 2009 H1N1 Risk
NCT01001325Phase 3Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by Mount Sinai Hospital. Started Oct 2009; status: completed.
02
Drugs
influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01001325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001325.